National Center for Advancing Translational Sciences; Notice of Closed Meeting, 78052 [2023-25070]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
78052
Federal Register / Vol. 88, No. 218 / Tuesday, November 14, 2023 / Notices
73. Kathleen Staub, Dresher, Pennsylvania,
Court of Federal Claims No: 23–1611V
74. Shireesha Eedunuru on behalf of R. R. K.,
Sugarland, Texas, Court of Federal
Claims No: 23–1613V
75. Anna Hoffman, Summit, Wisconsin,
Court of Federal Claims No: 23–1614V
76. Sarah Leah Ganzweig, New York, New
York, Court of Federal Claims No: 23–
1615V
77. Adi Eminente, Los Angeles, California,
Court of Federal Claims No: 23–1616V
78. Nancy Hodges, Fresno, California, Court
of Federal Claims No: 23–1617V
79. Debora Strader, Escondido, California,
Court of Federal Claims No: 23–1619V
80. Dairinn Finn, Olean, New York, Court of
Federal Claims No: 23–1620V
81. Gabrielle Rawnsley, Charleston, New
Hampshire, Court of Federal Claims No:
23–1621V
82. James A. Bristol, Jr., McKinney, Texas,
Court of Federal Claims No: 23–1622V
83. Jamie Whitehouse, Helena, Montana,
Court of Federal Claims No: 23–1623V
84. Christal Hanson, Boston, Massachusetts,
Court of Federal Claims No: 23–1624V
85. Karen Bergin, New London, Connecticut,
Court of Federal Claims No: 23–1625V
86. Amanda Page, Louisburg, North Carolina,
Court of Federal Claims No: 23–1626V
87. Nazeer Lotfi-Fard, Avon, Ohio, Court of
Federal Claims No: 23–1627V
88. Travis Rian, Wellesley, Massachusetts,
Court of Federal Claims No: 23–1628V
89. Eugene Hieger, Lexington, Kentucky,
Court of Federal Claims No: 23–1630V
90. Wendy Wright, Lewiston, Idaho, Court of
Federal Claims No: 23–1631V
91. Bruce A. Scott, Fort Recovery, Ohio,
Court of Federal Claims No: 23–1632V
92. Kathleen Hicks, Mechanicsville, Virginia,
Court of Federal Claims No: 23–1634V
93. Rebecca Fellows, Lebanon, New
Hampshire, Court of Federal Claims No:
23–1636V
94. Natalie Gaines, Columbia, Maryland,
Court of Federal Claims No: 23–1637V
95. Michael Todaro, Dresher, Pennsylvania,
Court of Federal Claims No: 23–1638V
96. Nicole Schaefer, Charleston, South
Carolina, Court of Federal Claims No:
23–1641V
97. Annie Murphy, Ann Arbor, Michigan,
Court of Federal Claims No: 23–1642V
98. Kristena Rivera on behalf of L. R.,
Dresher, Pennsylvania, Court of Federal
Claims No: 23–1644V
99. Kerri Stone on behalf of E. L., Lexington,
South Carolina, Court of Federal Claims
No: 23–1645V
100. Toni Rankin, Beverly Hills, California,
Court of Federal Claims No: 23–1646V
101. Gregory Whitehouse, Boston,
Massachusetts, Court of Federal Claims
No: 23–1647V
102. Melvin J. Martin on behalf of Billy J.
Martin, Deceased, Greensboro, North
Carolina, Court of Federal Claims No:
23–1649V
103. James Brady, Boston, Massachusetts,
Court of Federal Claims No: 23–1650V
104. Julio Castillo, South Jordan, Utah, Court
of Federal Claims No: 23–1651V
105. Jesus Villahermosa, Gig Harbor,
Washington, Court of Federal Claims No:
VerDate Sep<11>2014
16:48 Nov 13, 2023
Jkt 262001
23–1652V
106. Theresa V. Barrows, Cambridge,
Vermont, Court of Federal Claims No:
23–1653V
107. Grisel Escalera, Providence, Rhode
Island, Court of Federal Claims No: 23–
1654V
108. Margaret Carter, Dresher, Pennsylvania,
Court of Federal Claims No: 23–1656V
109. Stacy Brown-Satterwhite, Greensboro,
North Carolina, Court of Federal Claims
No: 23–1658V
110. Jerilynn Vokurka, Phoenix, Arizona,
Court of Federal Claims No: 23–1659V
111. Debra Legleiter, Harrison, Arkansas,
Court of Federal Claims No: 23–1660V
112. Brenda Smull, Chandler, Arizona, Court
of Federal Claims No: 23–1662V
113. Lois Blankenship on behalf of Carter
Blankenship, Deceased, Crown Point,
Indiana, Court of Federal Claims No: 23–
1663V
114. Curtis Lovejoy, Altamont, Illinois, Court
of Federal Claims No: 23–1664V
115. Evelyn Fisher, Bensalem, Pennsylvania,
Court of Federal Claims No: 23–1665V
116. Mary Palmisano, New Brunswick, New
Jersey, Court of Federal Claims No: 23–
1666V
117. Alina Dennis, Chula Vista, California,
Court of Federal Claims No: 23–1670V
118. Julie Brown, Libertyville, Illinois, Court
of Federal Claims No: 23–1671V
119. Raymond Motyka, East Orange, New
Jersey, Court of Federal Claims No: 23–
1672V
120. Carl Bildner, Columbia, Missouri, Court
of Federal Claims No: 23–1673V
121. Deborah Bagdazian, San Diego,
California, Court of Federal Claims No:
23–1674V
122. Misty Fuller, Glenwood Springs,
Colorado, Court of Federal Claims No:
23–1677V
123. Jeanne Carpenter, Glen Burnie,
Maryland, Court of Federal Claims No:
23–1678V
124. John J. Reding, Jr., Seattle, Washington,
Court of Federal Claims No: 23–1679V
125. Gina Goldmann, Islandia, New York,
Court of Federal Claims No: 23–1681V
126. Bruce W, Blais, Jr., Providence, Rhode
Island, Court of Federal Claims No: 23–
1682V
127. Von-Ikenna Marie Tresna-Taylor,
Fulton, Missouri, Court of Federal
Claims No: 23–1687V
128. Kenneth Berard, Vancouver,
Washington, Court of Federal Claims No:
23–1690V
129. Bradley McKinnon, Little Rock,
Arkansas, Court of Federal Claims No:
23–1691V
130. Melinda Boards, Bowling Green,
Kentucky, Court of Federal Claims No:
23–1692V
131. Dora D. Loiacono, West Caldwell, New
Jersey, Court of Federal Claims No: 23–
1693V
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2023–25043 Filed 11–13–23; 8:45 am]
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
BILLING CODE 4165–15–P
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Preclinical Proof of Concept
Studies for Rare Diseases (R21) Review
Meeting.
Date: January 24–25, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Carol (Chang-Sook) Kim,
Ph.D., Scientific Review Administrator,
Scientific Review Branch, Division of
Extramural Activities, National Center for
Advancing Translational Sciences, National
Institutes of Health, 6701 Democracy
Boulevard, MSC 4874 Bethesda, MD 20892,
(301) 402–1744, carol.kim@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: November 8, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–25070 Filed 11–13–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
E:\FR\FM\14NON1.SGM
14NON1
]]>Agencies
[Federal Register Volume 88, Number 218 (Tuesday, November 14, 2023)]
[Notices]
[Page 78052]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-25070]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; Preclinical Proof of Concept
Studies for Rare Diseases (R21) Review Meeting.
Date: January 24-25, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Center for Advancing Translational Sciences,
National Institutes of Health, 6701 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Carol (Chang-Sook) Kim, Ph.D., Scientific Review
Administrator, Scientific Review Branch, Division of Extramural
Activities, National Center for Advancing Translational Sciences,
National Institutes of Health, 6701 Democracy Boulevard, MSC 4874
Bethesda, MD 20892, (301) 402-1744, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
Dated: November 8, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-25070 Filed 11-13-23; 8:45 am]
BILLING CODE 4140-01-P
